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Abstract. 
 
The dissociation, migration, and remodeling 
of epithelial monolayers induced by hepatocyte growth 
factor (HGF) entail modifications in cell adhesion and 
in the actin cytoskeleton through unknown mecha-
nisms. Here we report that ezrin, a membrane–cyto-
skeleton linker, is crucial to HGF-mediated morpho-
genesis in a polarized kidney-derived epithelial cell 
line, LLC-PK1. Ezrin is a substrate for the tyrosine ki-
nase HGF receptor both in vitro and in vivo. HGF stim-
ulation causes enrichment of ezrin recovered in the de-
tergent-insoluble cytoskeleton fraction. Overproduction 
of wild-type ezrin, by stable transfection in LLC-PK1 
cells, enhances cell migration and tubulogenesis in-
duced by HGF stimulation. Overproduction of a trun-
cated variant of ezrin causes mislocalization of endoge-
nous ezrin from microvilli into lateral surfaces. This is 
concomitant with altered cell shape, characterized by 
loss of microvilli and cell flattening. Moreover, the 
truncated variant of ezrin impairs the morphogenic and 
motogenic response to HGF, thus suggesting a domi-
nant-negative mechanism of action. Site-directed mu-
tagenesis of ezrin codons Y145 and Y353 to phenylala-
nine does not affect the localization of ezrin at microvilli, 
but perturbs the motogenic and morphogenic responses 
to HGF. These results provide evidence that ezrin dis-
plays activities that can control cell shape and signaling.
 
T
 
he
 
 so-called epithelial–mesenchymal transitions,
such as migration in embryonic development, inva-
sion, and metastasis, are important processes occur-
ring in both physiological and pathological situations. Mes-
enchymal cells secrete hepatocyte growth factor (HGF)
 
1
 
, a
glycoprotein which acts in a paracrine fashion to induce
the proliferation, dissociation, motility (scattering), and in-
vasiveness of epithelial cells (Comoglio and Vigna, 1995).
HGF has also recently been shown to be a survival factor
(Bardelli et al., 1996) and to protect cells from “anoikis,” a
form of apoptosis induced by disruption of cell adhesion
(Frisch and Francis, 1994; Amicone et al., 1997). Through
the concerted activation of these complex biological re-
sponses, HGF directs the remodeling of epithelial cells
grown in three-dimensional collagen gels in vitro (Monte-
sano et al., 1991; Berdichevsky et al., 1994; Brinkmann et
al., 1995; Soriano et al., 1995; Medico et al., 1996), pro-
motes branching morphogenesis in mammary gland (Yang
et al., 1995) and metanephric organ cultures (Woolf et al.,
1995), and stimulates angiogenesis in vivo (Bussolino et
al., 1992; Grant et al., 1993). It is also involved in develop-
ment of the spinal cord during embryogenesis (Bronner-
Fraser, 1995). Disruption of HGF or HGF-receptor genes
by homologous recombination shows that they have a ma-
jor function for placental, liver, and limb muscle develop-
ment in vivo (Bladt et al., 1995; Schmidt et al., 1995; Ue-
hara et al., 1995; Maina et al., 1996). Thus HGF also
controls migration of myogenic precursor cells from the
somites to the limb bud.
The diverse biological effects of HGF are transmitted
through activation of its transmembrane receptor, the ty-
rosine kinase encoded by the c-
 
met
 
 proto-oncogene (Bot-
taro et al., 1991; Naldini et al., 1991). In epithelial cells, the
HGF-receptor is localized at the lateral surface (Prat et al.,
1991
 
a
 
; Crepaldi et al., 1994). The mechanisms by which
HGF triggers cell motility clearly depend on the activation
of multiple intracellular molecular pathways. Different
molecules containing SH2 domains bind to the tyrosine-
phosphorylated HGF-receptor (Graziani et al., 1991;
Bardelli et al., 1992; Ponzetto et al., 1994; Pelicci et al.,
1995). So far, the roles of Shc, Ras, PI3-kinase, and PLC-
 
g
 
in the HGF-mediated motility signal have been estab-
lished. Overproduction of Shc increases cell motility in re-
sponse to HGF (Pelicci et al., 1995). The expression of a
dominant-negative mutant Ras protein (Hartmann et al.,
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1994) and the microinjection of a neutralizing antibody for
Ras (Ridley et al., 1995) block HGF-induced dissociation
and scattering of MDCK epithelial cells. Drug inhibition
studies suggest that PI3-kinase (Derman et al., 1996; Royal
and Park, 1995) and phospholipase C-(PLC)-
 
g
 
 (Derman et
al., 1996) activation are required for HGF-induced motil-
ity. More recently, an insulin receptor 1–like substrate
(Gab1) has been identified to bind specifically to c-met by
the yeast two-hybrid system. Its overproduction in MDCK
cells is sufficient to induce scattering and tubulogenesis
(Weidner et al., 1996). However, the mechanisms by which
HGF triggers cell motility and coordinates the cell adhe-
sion system with the actin cytoskeleton machinery are not
known. Cytochalasin D treatment prevents MDCK scat-
tering (Rosen et al., 1990), suggesting the involvement of
the actin cytoskeleton machinery. The small GTP-binding
proteins, Rac (Ridley et al., 1995) and Rho (Nishiyama et
al., 1994), are involved in HGF-induced membrane ruf-
fling. Several proteins, including 
 
b
 
-catenin, plakoglobin
(Shibamoto et al., 1994), and focal adhesion kinase (Mat-
sumoto et al., 1994), implicated in the control of cell adhe-
sion, are tyrosine phosphorylated after stimulation with
HGF. Here we report that ezrin, a membrane–cytoskeleton
linker, is a downstream target of the HGF-receptor. We
show that ezrin is required for the motility and morphoge-
netic responses induced by HGF in the kidney-derived
LLC-PK1 cell line.
Ezrin and the two closely related proteins radixin and
moesin constitute the ezrin-radixin-moesin (ERM) pro-
tein family. The ERMs belong to a superfamily of proteins
whose prototypes are talin and band 4.1, two proteins
whose roles in membrane-cytoskeleton interaction are
well documented (for review see Arpin et al., 1994; Tsu-
kita et al., 1997). That ezrin too has a similar role is sup-
ported by the following: (
 
a
 
) it is primarily expressed in the
microvilli and other actin-rich surface projections (Bretscher,
1983; Berryman et al., 1993); (
 
b
 
) it associates with various
membrane proteins such as the hyaluronan receptor CD44
(Tsukita et al., 1994), ICAM-2 (Helander et al., 1996), and
type II cAMP–dependent protein kinases (Dransfield et
al., 1997); (
 
c
 
) its COOH-terminal domain is capable of di-
rect association with F-actin in vitro (Turunen et al., 1994;
Pestonjamasp et al., 1995) and in vivo (Algrain et al.,
1993), while the complete protein binds poorly to F-actin
in solution. The last observation suggests that the F-actin
binding site could be masked in the wild-type protein, an
observation confirmed when ezrin was found to be capa-
ble of intermolecular associations leading to homo- and
hetero-oligomerization (Gary and Bretscher, 1993; Andre-
oli et al., 1994; Berryman et al., 1995; Bretscher et al.,
1995). Moreover, it has been shown that in the native ezrin
molecule, the F-actin binding site and the oligomerization
domains are masked by intramolecular association be-
tween head and tail domains (Gary and Bretscher, 1995).
Thus, it has been suggested that both interaction with F-actin
and oligomerization contribute to the assembly of cell sur-
face structures, like microvilli and membrane ruffles (Ber-
ryman et al., 1995). Regulatory signals (for example, phos-
phorylation) are likely to change the protein conformation
and unmask the F-actin binding site and the oligomeriza-
tion domains. To further support this model, it was shown
that overproduction of the COOH-terminal half of ezrin
alone displays morphogenic effects in transfected cells
(Martin et al., 1995), and these effects can be inhibited by
concomitant overproduction of the NH
 
2
 
-terminal half.
We report that ezrin is a downstream target of the HGF-
receptor for the following reasons: (
 
a
 
) Ezrin is a substrate
for the tyrosine kinase HGF-receptor (
 
b
 
) Overproduction
of the wild-type ezrin enhances the motility response to
HGF, as measured by the faster healing of a wound made
in subconfluent cell monolayer, as well as cyst and tubule
formation of LLC-PK1 cells grown in collagen gels. (
 
c
 
) In-
troduction of the NH
 
2
 
-terminal half of ezrin into LLC-
PK1 cells induces the redistribution of endogenous ezrin
from apical microvilli to lateral cell–cell contacts, and the
loss of functional ezrin alters the cell shape and impairs
the HGF-mediated cell migration and tubulogenesis. (
 
d
 
)
Mutations of Y145 and Y353 to phenylalanine also alter
the response to HGF. Thus, ezrin seems to play a critical
role in coordinated control of cell shape, motility, and sig-
naling.
 
Materials and Methods
 
Cells, Recombinant Proteins, and Antibodies
 
LLC-PK1 (CCL 101; American Type Culture Collection, Rockville, MD)
and MDCK (CCL 34; American Type Culture Collection) cells were
grown in DME growth medium (GIBCO BRL, Gaithersburg, MD) sup-
plemented with 10% FCS and maintained at 37
 
8
 
C in 10% CO
 
2
 
. As a
source of HGF we used either dia-filtered, human fibroblast MRC5-con-
ditioned medium or purified recombinant HGF from the baculovirus ex-
pression system (Naldini et al., 1995), kindly provided by Dr. C. Stella, In-
stitute for Cancer Research, University of Torino, Italy. The two
preparations yielded 3 and 0.9 
 
m
 
g/ml purified protein, respectively (0.3 ng 
 
5
 
1 scatter unit). The glutathione-S-transferase–fused kinase domain of
c-
 
MET
 
 cDNA was cloned into baculovirus vector as described (Bardelli et
al., 1992) and kindly provided by Dr. A. Bardelli, Institute for Cancer Re-
search. PGEX-2T plasmids containing the cDNA coding for the full-
length ezrin and for its NH
 
2
 
-terminal domain (amino acids 1–309) were
constructed and used for the production of fusion proteins as previously
described (Andreoli et al., 1994).
P5D4 mAb raised against the 11–amino acid COOH terminus of the
vesicular stomatitis virus glycoprotein G (VSVG) was previously de-
scribed (Kreis, 1986). The DO-24 mAb was raised against the extracellu-
lar domain of the HGF-receptor (Prat et al., 1991
 
b
 
). Rabbit polyclonal
anti-ezrin antibody was raised against the entire ezrin produced in bacte-
ria and was previously described (Algrain et al., 1993). Rabbit polyclonal
anti-phosphotyrosine and anti–ZO-1 antisera were purchased from
Zymed Laboratories (South San Francisco, CA). Rabbit polyclonal anti–
p62
 
c-yes
 
 antiserum was from Santa Cruz Biotechnology (Santa Cruz, CA)
and mAb anti–
 
b
 
-catenin was from Transduction Laboratories (Lexington,
KY). Antisera against GST were produced by Dr. M Arpin.
 
DNA Constructs and Transfection
 
cDNA coding for either wild-type or NH
 
2
 
-terminal domain of human
ezrin were fused to oligonucleotides encoding the 11–amino acid COOH
terminus of the VSVG as described (Algrain et al., 1993). The fused cDNAs
were then inserted into the expression vector pCB6, downstream from the
cytomegalovirus promoter. For generating the plasmid-producing ezrin
mutated on tyrosines 145 and 353, the following constructs were made:
to make the F353 mutant, the two oligonucleotides, 5
 
9
 
 CGGAATT-
CCGGCTGCAGGACTTTGAGGAG 3
 
9
 
 and 5
 
9
 
 CGCGGATCCATTG-
TGGGTCCTCTTA 3
 
9
 
 (flanked with EcoRI and BamHI restriction sites,
respectively), were used to amplify the fragment (nucleotides 1,125–1,730)
using the Ampli Taq polymerase (Perkin-Elmer Corp., Norwalk, CT).
This fragment was then subcloned into the Bluescript plasmid and
checked by double-strand DNA sequencing using the T7 sequencing kit
(Pharmacia Fine Chemicals, Piscataway, NJ). The PstI–PstI fragment cor-
responding to the sequence 1,131–1,197 and containing the mutated codon
was inserted into the AvaI–AvaI fragment (nucleotides 1,002–1,698) in 
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the plasmid psp64. The AvaI–AvaI fragment of the full-length ezrin
cDNA in the plasmid psp64 was then replaced by the AvaI–AvaI frag-
ment containing the mutated codon. To make the F145 mutant, a double
amplification by PCR was performed with the Taq polymerase. A first
amplification was made with the oligonucleotides 5
 
9
 
 ATCCATGCC-
GAAACCAATCAATGTCCGAGTTACCAC 3
 
9
 
 and 5
 
9
 
 AGAGCTGAG-
GAACCCAGACTT 3
 
9
 
. The fragment generated was used as a primer to
perform a second amplification with the oligonucleotide 5
 
9
 
 GTTCCT-
GATTTCACTCCAAG 3
 
9
 
. The fragment obtained was inserted into the
plasmid pCR
 
TM
 
II, using the TA cloning site (Invitrogen, Carlsbad, CA),
and checked by the double-strand DNA sequencing. The plasmid was
then digested by the unique restriction sites NcoI and HpaI corresponding
to the sequence 108–777. This fragment with the mutated codon was then
inserted in the ezrin cDNA containing the F353 mutant. This double mu-
tant ezrin cDNA was then cloned in the expression vector pCB6 through
the HindIII and XbaI restriction sites. Exponentially growing LLC-PK1
cells were seeded 24 h before DNA transfer on 10-cm tissue culture
dishes. DNA transfer was performed following the procedure of Chen and
Okayama (1987), and transfected cells were selected by growing in media
containing 0.7 mg/ml G-418 for 2–3 wk. For each transfection, three/four
clones which overproduced the transfected protein (as detected by immu-
noblot and immunofluorescence analysis) were selected for further study.
 
Indirect Immunofluorescence and Scanning
Electron Microscopy
 
For indirect immunofluorescence studies, cells grown on coverslips were
fixed with 3% paraformaldehyde, permeabilized with 0.5% Triton X-100,
incubated first with primary antibodies, and then incubated with
rhodamine- or fluorescein-conjugated secondary antibodies. Samples
were viewed with Zeiss epifluorescence optics (Carl Zeiss, Inc., Thorn-
wood, NY). For confocal laser scanner microscopy (CLSM), cells were
seeded at 2.2 
 
3
 
 10
 
5
 
/cm
 
2
 
 on 12-mm Transwells filters, grown for 4 d, and
processed for indirect immunofluorescence. Affinity-purified polyclonal
anti-ezrin and monoclonal P5D4 antibodies were added to both apical and
basolateral compartments of the Transwell unit. Transwell filters were
then incubated with rhodamine-coupled anti–rabbit, and fluorescein-
linked anti–mouse IgG antibodies, mounted on glass slides in a solution of
Mowiol (Calbiochem-Novabiochem Corp., La Jolla, CA) and viewed on a
Leica CLSM (Vienna, Austria). For each X-Y section, the intensity of flu-
orescence was determined with arbitrary units 1–255. All readings were
normalized to this scale. All X-Y sections were summed, and the intensi-
ties were averaged and represented with the color scale on two dimen-
sions.
Scanning EM was carried out on cultures grown on coverslips to con-
fluency. After fixation with 2% glutaraldehyde in cacodylate buffer, cul-
tures were postfixed in 2% OsO
 
4
 
 aqueous solution and dehydrated in a
graded series of ethanol incubation. Wet coverslips were transferred into
Freon 113 and dried after substitution with liquid CO
 
2
 
 in a Balzers critical
point drier (Balzers S.P.A., Milan, Italy). Dried cultures were coated with
gold with a Polaron gold sputter coater (Polaron Instruments, Inc., Hat-
field, PA). Samples were viewed with a scanning electron microscope.
 
Biological Assays
 
For the wound healing assay 1.5 
 
3
 
 10
 
6
 
 cells were seeded into 35-mm plate
wells and grown for 48 h. Cells were washed with DME, and a wound was
marked in the confluent monolayer using a plastic pipet tip. Cells were
then incubated for 15 h in the presence of 0.2% FCS, 
 
6
 
15 ng/ml HGF. Af-
ter wounding, time-lapse video microscopy was performed with an Axio-
vert 135 inverted microscope (Carl Zeiss, Inc., Thornwood, NY) linked to
a camera. Motility measurements of the margins of the wound were per-
formed over time with a micrometer.
For the tubulogenesis assay in three-dimensional collagen gels, the
trypsinized cells were suspended at a final concentration of 1 
 
3
 
 10
 
5
 
 cells
per ml in gelling solution, prepared as follows: 1 part DME 10
 
3
 
 (GIBCO
BRL), 1 part NaHCO
 
3
 
 (37 g/liter), and 1 part FCS all were mixed with 3.5
parts of a suspension of 3 
 
3
 
 10
 
5
 
 cells per ml, and 3.5 parts of type I col-
lagen at 5 mg/ml (Becton Dickinson, Bedford, MA) at room temperature.
100 
 
m
 
l of this mixture was seeded in a microtiter plate onto 100 
 
m
 
l of a first
layer of collagen without cell suspension. After 5 min at 37
 
8
 
C, the gels
were covered with cell culture medium 
 
6
 
30 ng/ml HGF. Photographs
were taken with a light microscope (Leica) equipped with Nomarski inter-
ference optics. To analyze the structure of the tubules, cells were fixed
with 4% paraformaldehyde, and embedded in 10% gelatin at 37
 
8
 
C. Small
blocks were cut from the gel and frozen in liquid nitrogen in the presence
of 2.5 M sucrose. Semithin sections were stained with toluidine blue and
analyzed with a light microscope (Axiophot; Carl Zeiss, Inc.).
For the cell proliferation assay, the Amersham kit (Amersham Intl.,
Little Chalfont, UK) was used to measure incorporation of the thymidine
analogue 5-bromo-2
 
9
 
-deoxyuridine (BrdU) into nascent DNA. Briefly,
cells were plated in microtiter plate to reach confluence, starved in DME
0.2% FCS for 24 h, and then stimulated with 15 ng/ml of HGF. After 6 h,
BrdU was added and left to incorporate for another 3 h. Incorporated
BrdU was detected by a specific mAb and a peroxidase-conjugated sec-
ondary antibody. Incubation with chromogen peroxidase substrate
yielded a soluble green dye with absorbance at 410 nm.
 
HGF Stimulation, Cell Lysis, and Immunoprecipitation
 
Cells were seeded at 1.5 
 
3
 
 10
 
4
 
/cm
 
2
 
 on 24.5-mm Transwell filters, grown
for 3 d in spent medium, and then stimulated with DME containing 25
mM Hepes, 100 
 
m
 
g/ml bacitracin, 0.05% BSA, with or without 120 ng/ml
of HGF for 10 min at 37
 
8
 
C. Four Transwell filters were used for each im-
munoprecipitation. Cells were washed at 4
 
8
 
C and lysed in 20 mM Tris-
HCl, pH 7.4, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1% deoxycholic
acid, sodium salt, 5 mM EDTA, 1 mM Na
 
3
 
VO
 
4
 
 (RIPA buffer), and inhibi-
tors of proteases (2 mM PMSF [Sigma Chemical Co., Poole, UK], 50 
 
m
 
g/
ml pepstatin, 50 
 
m
 
g/ml chymostatin, and 10 
 
m
 
g/ml antipain [Chemicon
Intl., Inc., Temecula, CA]) for 15 min on ice. Clarified cell extracts were
rotated 2 h at 4
 
8
 
C with antibodies covalently linked to Sepharose protein
A by cross-linking with dimethyl pimelimidate (Pierce Chemical Co.,
Rockford, IL). Beads were washed three times with lysis buffer and sam-
ples were eluted by boiling in Laemmli buffer containing 100 mM DTT.
Eluted proteins were electrophoresed on 7% and 10% SDS-PAGE, trans-
ferred to nitrocellulose, and probed with specific primary and secondary
antibodies. Immunoblots were developed with an enhanced chemilumi-
nescence kit (ECL; Amersham Intl.), according to the instructions of
manufacturer, and visualized on XOMAT AR films (Eastman Kodak Co.,
Rochester, NY).
 
Cell Fractionation into Detergent-soluble
and -insoluble Fractions
 
Cells were seeded at 6 
 
3
 
 10
 
4
 
/cm
 
2
 
 on 24.5-mm Transwell filters, grown for 3 d
in spent medium, and then stimulated with 120 ng/ml of HGF for 10 min
at 37
 
8
 
C. Cells were extracted on the filters for 40 s at room temperature
with 300 
 
m
 
l of the extraction buffer MES [50 mM 2-(
 
N
 
-morpholino)
ethane sulfonic acid, 3 mM EGTA, 5 mM MgCl
 
2
 
, 0.5% Triton X-100, pH
6.4]. Detergent-soluble fractions were precipitated for 3 h in 85% acetone
at 
 
2
 
20
 
8
 
C and the pellets were recovered after centrifugation for 10 min at
300 
 
g
 
 at 4
 
8
 
C. These pellets and the detergent-insoluble material were re-
suspended in the same volume of Laemmli buffer before protein separa-
tion on a 7% SDS-PAGE and transfer to nitrocellulose. The blots were ei-
ther probed with the polyclonal anti-ezrin antibody or with the
monoclonal anti-tag antibody (P5D4), and were developed with an en-
hanced chemiluminescence kit. The bands were quantitated on a Bio-Pro-
fil station (Vilbert-Lourmat, Marne-La-Vallée, France). The protein lev-
els were normalized to the sum of protein in the supernatant and pellet
fractions.
 
In Vitro Kinase Assay
 
Sf9 cells expressing the recombinant GST-fused kinase domain of HGF-
receptor (
 
z
 
2 
 
3
 
 10
 
6
 
 cells per point) were lysed 48 h after infection, in
buffer A (10 mM Tris-HCl buffer, pH 7.5, 150 mM NaCl [TBS], 10% glyc-
erol, 1% Triton X-100, 5 mM EDTA), and inhibitors of proteases (2 mM
PMSF [Sigma Chemical Co.], 50 
 
m
 
g/ml pepstatin, 50 
 
m
 
g/ml chymostatin,
and 10 
 
m
 
g/ml antipain [Chemicon Inc.]) for 15 min at 4
 
8
 
C. Clarified cell ly-
sates were coupled to glutathione–Sepharose beads for 1 h at 4
 
8
 
C. The
beads were washed two times with buffer A and once with buffer B (25
mM Hepes buffer, pH 7.2, 100 mM NaCl, 5 mM MgCl
 
2
 
, 0.1% Triton
X-100). The in vitro kinase assay was performed in 100 
 
m
 
l of buffer B con-
taining 0.1 mM Na
 
3
 
VO
 
4
 
, 0.1 mM ATP, with or without 12 
 
m
 
g ezrin or
NH
 
2
 
-terminal domain of ezrin fused to GST for 5 min at 30
 
8
 
C. Beads
were washed twice with TBS–10 mM EDTA; proteins were eluted by
boiling in Laemmli buffer, electrophoresed on 10% SDS-PAGE, and
Western blotted with anti-phosphotyrosine and anti-GST polyclonal anti-
bodies. 
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Results
 
Isolation of LLC-PK1 Cells Overproducing Wild-Type 
Ezrin or NH
 
2
 
-terminal Domain of Ezrin
 
LLC-PK1 is a polarized epithelial cell line derived from
the proximal tubules of pig kidney (Pfaller et al., 1990). It
displays a well-developed brush border at the apical sur-
face. We generated stable transfectants using the pCB6
eukaryotic expression vector, which carries cDNA con-
structs coding for wild-type ezrin or its NH
 
2
 
-terminal do-
main (amino acids 1–309), as previously described (Al-
grain et al., 1993). Both cDNAs were fused at the COOH
terminus to oligonucleotides encoding the 11–amino acid
COOH terminus of the VSVG, which allowed discrimina-
tion between the transfected and endogenous ezrins. The
G418-resistant colonies were screened for transfected
ezrin expression by anti-tag antibody reactivity in Western
blot and immunofluorescence. Protein levels in the trans-
fected cells were determined by quantitative immunoblot-
ting of total cell extracts (0.1–2 
 
m
 
g), and then compared to
that of endogenous ezrin in untransfected LLC-PK1 cells
(Fig. 1). Clones E7 (transfected with wild-type ezrin) and
N2 (transfected with the NH
 
2
 
-terminal domain of ezrin)
produced high protein levels by Western blot analysis (10-
fold and threefold the endogenous ezrin level, respec-
tively), and relatively homogenous and strong staining by
immunofluorescence with anti-tag antibody (Fig. 2). Four
other independent clones with similar features analyzed
during the study gave identical results as E7 and N2 cells.
LLC-PK1 cells transfected with vector alone behaved like
untransfected LLC-PK1 cells.
 
Overproduction of the NH
 
2
 
-terminal Domain of Ezrin 
Prevents Microvilli Formation
 
The E7 cells displayed a phenotype similar to that of the
parental cell line, while the N2 cells were quite different.
When grown at low density, N2 cells were flattened and
spread out; at confluency, they had a spindle-like cell
shape (Fig. 2, 
 
B
 
 and 
 
B
 
9
 
). In immunofluorescence, the
transfected NH
 
2
 
-terminal domain of ezrin was found in
the cytosol and underneath the membranes, mainly con-
centrated along the lateral surface at cell–cell boundaries
(Fig. 2). It did not colocalize with actin-stress fibers (Fig. 2,
 
B
 
 and 
 
B
 
9
 
), as already reported for CV1 cells (Algrain et
al., 1993). However, we observed an increase in the
amount of stress fibers in the N2 cells (Fig. 2 
 
B
 
9
 
). Three-
dimensional analysis by CLSM of endogenous ezrin and
transfected NH
 
2
 
-terminal domain of ezrin in N2 cells re-
vealed the expression of both proteins to be reduced at the
apical surface and now concentrated at lateral surfaces.
Cells producing wild-type ezrin did not show comparable
pattern (Fig. 3 
 
A
 
). The distribution of tight and adherens
junction markers, such as ZO-1 and 
 
b
 
-catenin, was un-
changed (data not shown). Scanning EM of N2 cells
showed that their microvilli were severely reduced in num-
ber and shorter in length (Fig. 3 
 
B
 
). Notably, a row of long
microvilli was present at cell–cell contacts. On the con-
trary, untransfected LLC-PK1 cells showed a well-devel-
oped brush border.
Altogether, these results suggest that the production of
the NH
 
2
 
-terminal domain of ezrin in LLC-PK1 cells impedes
the correct localization of endogenous ezrin by a domi-
nant-negative mechanism. This is concomitant with im-
paired microvilli formation.
 
Ezrin Is a Substrate of HGF-Receptor
 
Ezrin is tyrosine phosphorylated upon stimulation with
growth factors (Bretscher, 1989; Fazioli et al., 1993). We
thus investigated if ezrin is a target for the tyrosine kinase
activity of the HGF-receptor (HGF-R), in vitro with the
recombinant proteins and in vivo using the N2 and E7
cells. The GST-fused HGF-R kinase domain, produced in
the baculovirus system, and the GST-fused wild-type ezrin
and NH
 
2
 
-terminal domain, produced in bacteria, were pu-
rified on glutathione–Sepharose and tested using an in
vitro kinase assay, followed by a Western blot with anti-
phosphotyrosine antibodies. Fig. 4 
 
A
 
 shows that the kinase
domain of HGF-R can phosphorylate itself and wild-type
ezrin. We found the NH2-terminal domain of ezrin to be
poorly phosphorylated by HGF-R in vitro (Fig. 4 A) and
not at all in vivo in N2 cells (Fig. 4 C, left). On the con-
trary, when E7 cells were stimulated in vivo with 120 ng/ml
HGF, ezrin and the b chain of HGF-R were phosphory-
lated (Fig. 4 B, left). Although ezrin did not coimmunopre-
cipitate with the HGF-R in LLC-PK1 cells, it did in
MDCK cells, a cell line derived from kidney distal tubules
(data not shown).
A phosphoprotein of 62 kD, which we identified as p62c-yes,
coprecipitated with ezrin in unstimulated E7 (Fig. 4 B,
right). In unstimulated N2 cells, p62c-yes was also found as-
sociated with the NH2-terminal domain of ezrin (Fig. 4 C).
On HGF stimulation of E7 and N2 cells, p62c-yes did not
coimmunoprecipitate with ezrin or its NH2-terminal do-
main, but did associate with HGF-R (Fig. 4, B and C,
right). We previously showed that the SH2 domain of the
nonreceptor tyrosine kinase pp60c-src binds the HGF-R in
vitro and in vivo (Ponzetto et al., 1994). p62c-yes in particu-
lar, another member of the src family, was found enriched
in purified preparations of adherens junctions (Tsukita et
al., 1991), indicating that it has a subcellular distribution
similar to that of HGF-R.
HGF-induced Cell Migration Is Enhanced by 
Overproduction of Wild-Type Ezrin but Impaired by 
Overproduction of its NH2-terminal Domain
HGF treatment induces cell spreading and cell shape
changes in LLC-PK1 cells. It also stimulates membrane
ruffling on the apical surface of these cells, with a concom-
Figure 1. Protein levels of endoge-
nous and transfected ezrin. Serial
dilutions of total cell extracts (0.1–2
mg) were run on a 7% SDS-PAGE
under reducing conditions, and
transferred to nitrocellulose mem-
branes. The membranes were
probed with polyclonal anti-ezrin
antibody (lanes A–C) and mono-
clonal P5D4 antibody (lane D), followed by peroxidase-conju-
gated secondary antibody, and developed with chemiluminescence.
(Lanes A–D) 1 mg of total cell extract. (Lane A) LLC-PK1 cells;
(lane B) E7 cells; (lane C) FF1 cells (see p. 428); (lane D) N2 cells.Crepaldi et al. Ezin Is an Effector of the HGF-mediated Signaling 427
itant disassembly of the microvilli. However, LLC-PK1
cells do not totally disrupt their cell–cell contacts and do
not move apart from each other in the conventional scat-
ter assay used for MDCK cells (data not shown). This find-
ing likely reflects either an elevated strength in cell–cell
adhesion in LLC-PK1 cells (which is indicated by their
higher resistance to low calcium treatment, compared to
MDCK cells [data not shown]) or a lower intrinsic motil-
ity. Thus, a standard cell motility assay appeared unsuit-
able for LLC-PK1 cells. Instead, we determined the rela-
tive motility of untransfected and transfected LLC-PK1
cells by measuring how far they had traveled into a wound
site after a 15-h incubation in the presence or absence of
HGF. To quantify the migration rates, cells were inspected
by videomicroscopy during the wound healing, and the
mean distance traveled by the margins of the wound was
plotted at definite time intervals (Fig. 5). E7 cells migrated
faster than untransfected cells, in response to 15 ng/ml of
HGF. On the contrary, N2 cells were almost unresponsive
to HGF. Since cell proliferation could also contribute to
wound healing in vitro, we estimated the degree of prolif-
eration in untransfected and transfected LLC-PK1 clones
by measuring the incorporation of BrdU into nascent
DNA, by serum-starved monolayers grown in the pres-
ence of HGF for 9 h (Table I). A significant and compara-
ble mitogenic activity was measured in transfected and un-
transfected cells.
To determine whether changes in the level of insoluble
ezrin pool in the LLC-PK1 cells and their mutants could
account for their different motility, we extracted the cells
with the nonionic detergent Triton X-100, and fraction-
ated the extracts between soluble and insoluble pool. In
LLC-PK1 cells, 30–40% of ezrin was associated with the
insoluble fraction. A similar ratio was observed with the
E7 cells overproducing wild-type ezrin. On the contrary, in
N2 transfectants, 70% of endogenous ezrin and the NH2-
terminal domain was found in the insoluble pellet. After
10 min of HGF treatment (120 ng/ml), we observed a sig-
nificant increase (10 to 20%) of the ezrin-insoluble pool in
control and E7 cells. On the contrary, the treatment of N2
transfectants with HGF led to a decrease (30%) of ezrin
and NH2-terminal domain in the insoluble fraction.
Taken together, these data suggest that ezrin is an impor-
tant element in epithelial cell locomotion induced by HGF.
Ezrin Plays a Crucial Role in
HGF-induced Morphogenesis
Kidney-derived epithelial cell lines retaining apical-baso-
lateral polarity form cysts when grown in three-dimen-
sional collagen gels and branch into tubular structures af-
ter HGF stimulation (Montesano et al., 1991; Barros et al.,
1995). We thus assayed the ability of LLC-PK1 parental
and transfected cells to undergo HGF-induced morpho-
Figure 2. Cellular distribu-
tion of ezrin and its mutants
in transfected LLC-PK1
cells by immunofluorescence
analysis. (A and A9) Cells
transfected with the cDNA
encoding the epitope-tagged,
full-length ezrin–E7 clone.
(B and B9) Cells transfected
with the cDNA encoding the
epitope-tagged NH2-terminal
domain of ezrin–N2 clone. (C
and  C9) Cells transfected
with the cDNA encoding the
epitope-tagged ezrin with
mutations of Y145 and Y353
into phenylalanine–FF1 clone.
Paraformaldehyde-fixed and
detergent-permeabilized cells
were double labeled with the
anti-tag mAb P5D4 followed
by incubation with FITC-
conjugated secondary anti-
body (A–C), and rhodamine-
coupled phalloidin (A9–C9).
Bar, 7 mm.The Journal of Cell Biology, Volume 138, 1997 428
genesis in vitro. When embedded in collagen gels, LLC-
PK1 cells formed cysts in 2–3 d (Fig. 6 A). In the presence
of 30 ng/ml HGF, the cysts were more abundant and some
of them developed into tubules (Fig. 6 C). The E7 cells
transfected with the full-length ezrin also formed cysts. In
the presence of HGF, the cysts developed into very elon-
gated tubules (three- to fivefold the control LLC-PK1
cells) with a lumen (Fig. 6 D, inset), as well as arboriza-
tions at the distal ends (Fig. 6 D). The N2 cells transfected
with the NH2-terminal domain of ezrin formed small cysts,
which scarcely developed into tubules in the presence of
HGF (Fig. 6 E). After few days in culture, they frequently
show cellular disorganization at the border of the cysts.
These results suggest that ezrin functions as an important
regulator of morphogenesis of kidney epithelial cells.
Tyrosine Phosphorylation of Ezrin Is Involved in
HGF-induced Motility and Morphogenesis
Since HGF stimulation leads to ezrin phosphorylation on
tyrosine residues (Fig. 4), we wanted to assess the possible
role of this phosphorylation in HGF-mediated responses.
Ezrin contains several potential tyrosine phosphorylation
sites fitting the consensus sequences defined for phospho-
tyrosine kinases (Songyang and Cantley, 1995). Two ty-
rosine residues Y145 and Y353 have been previously
shown to be phosphorylated by EGF-R (Krieg and
Hunter, 1992). Hence, we changed the tyrosines Y145 and
Y353 to phenylalanine by site-directed mutagenesis. The
mutated ezrin cDNA, again with the VSVG epitope, was
stably transfected into LLC-PK1 cells. Two G-418–resis-
tant clones (FF1; FF4) were isolated and characterized.
Figure 3. Dominant-negative effects of NH2-terminal domain of ezrin in LLC-PK1 cells. (A) E7 cells, (top) were labeled with the anti-
tag mAb P5D4 (E); N2 cells (bottom) were double labeled with mAb P5D4 (N) and rabbit polyclonal anti–ezrin antibody (E), which
does not recognize the NH2-terminal domain of ezrin. FITC-conjugated anti–mouse IgG and TRITC-conjugated anti–rabbit IgG sec-
ondary antibodies were used. Horizontal optical sections (insets) and three-dimensional analyses were obtained by CLSM. For each
X–Y section, the intensity of fluorescence was determined with arbitrary units 1–255. All readings were normalized to this scale. All
X–Y sections were summed, and the intensities were averaged and represented with the color scale on two dimensions. (B) LLC-PK1
cells (top) and N2 cells (bottom) were analyzed by scanning EM. Bar, 1 mm.Crepaldi et al. Ezin Is an Effector of the HGF-mediated Signaling 429
These two clones produced a high level of mutated ezrin
by Western blot (fivefold the endogenous protein; Fig. 1
C). Upon HGF treatment, mutated ezrin was still phos-
phorylated on tyrosine residues, suggesting that other ty-
rosine residues must be phosphorylated upon exposure of
cells to HGF. Moreover, a two-dimensional gel analysis of the
in vitro phosphorylated wild-type and mutated proteins
showed a different pattern (data not shown).
No apparent phenotypic changes were observed in FF1
cells grown on plastic or filters. By immunofluorescence,
the mutated ezrin was localized in microvilli and intracel-
lularly as in the E7 cells (Fig. 2, C and C9). However, the
HGF-induced motility of cells transfected with this double
tyrosine mutant was markedly reduced (Fig. 5). Moreover,
the tubulogenesis was completely abolished (Fig. 6, B and
F). After 2 or 3 d in collagen, the small cysts showed cellu-
lar disorganization (Fig. 6 F) and never formed tubules.
These results indicate that mutations of the two tyrosine
residues in ezrin impair cell motility and tubulogenesis
mediated by this protein.
Figure 4. Wild-type ezrin is a substrate of the HGF-tyrosine ki-
nase receptor. (A, left) In vitro kinase assay. GST-fused kinase
domain of HGF-receptor (apparent molecular mass, 45 kD) was
immobilized on glutathione–sepharose and incubated in the pres-
ence of 0.1 mM ATP alone (lane 1), with ezrin NH2-terminal do-
main (lane 2; apparent molecular mass, 38 kD), and with wild-
type ezrin (lane 3; apparent molecular mass, 80 kD). Beads were
washed, eluted in Laemmli buffer, and electrophoresed on 10%
SDS-PAGE. Western blots were probed with rabbit anti–phos-
photyrosine polyclonal antibodies. (Right) Western blot with
anti–glutathione-S-transferase (GST) antibodies. 2 mg of GST
proteins were loaded and detected with anti-GST polyclonal anti-
bodies. (B) Tyrosine phosphorylation of ezrin and HGF-receptor
and association of p62c-yes with ezrin and HGF receptor. E7 cells
were unstimulated (2) and stimulated (1) in vivo with 120 ng/ml
HGF, lysed, and immunocomplexes containing epitope-tagged
ezrin and HGF-R were probed in Western blot with anti-phos-
photyrosine antibodies (anti-PY; left two panels), and anti-p62c-yes
polyclonal antibodies (right two panels). (C) Tyrosine phosphory-
lation of the NH2-terminal domain of ezrin, and association of
p62c-yes with the ezrin NH2-terminal domain and HGF-R. N2 cells
were unstimulated (2) and stimulated (1) in vivo with 120 ng/ml
HGF, lysed, and immunocomplexes containing epitope-tagged
NH2-terminal domain of ezrin were probed in Western blot with
anti-phosphotyrosine, anti-tag, and anti-p62c-yes antibodies (left
three panels). Immunocomplexes obtained with anti-HGF-R anti-
body were probed in Western blot with anti-p62c-yes antibodies (right).
Figure 5. Wound healing abilities by LLC-PK1 cells transfec-
tants. A wound was scored in a confluent monolayer. The aver-
age distance traveled by the cell margin during HGF-stimulated
wound closure was measured with a micrometer for control cells
(LLC-PK1), E7 cells, N2 cells, and FF1 cells. SEM bars are
shown.
Table I. Mitogenic Effect of HGF on LLC-PK1 Cells
LLC-PK1 E7 Clone N2 Clone
1. 2HGF 88.2 6 16.0 88.8 6 5.6 90.0 6 7.9
2. 1HGF 149.8 6 18.0 150.0 6 22.0 138.0 6 12.4
4 3 104 cells were seeded in 96-well microtiter plate to reach confluence, starved in
DME 0.2% FCS for 24 h, and then stimulated with 15 ng/ml of HGF. After 6 h, BrdU
was added and left to incorporate for an additional 3 h. Incorporated BrdU was de-
tected by a specific mAb and peroxidase-conjugated secondary antibody. After incu-
bation with the peroxydase substrate, absorbance was read at 410 nm. Values are
given as OD arbitrary units. Numbers are the mean (6 SD) calculated from six dupli-
cates of one representative experiment. The t test was applied for specific comparisons
of the means of two pairs of samples in each column and in each row. Comparisons
between HGF-treated and untreated cells samples (1 vs 2) gave P < 0.01, while com-
parisons between samples of each row did not give significant P.The Journal of Cell Biology, Volume 138, 1997 430
Discussion
In this report we have shown that ezrin is an essential com-
ponent of epithelial morphogenesis and that it controls
processes induced by HGF signaling in a specific cell line.
Overproduction of the wild-type protein and suppression
of its function by dominant-negative mutants were pivotal
in uncovering its relevance in HGF signaling and in novel
cellular functions like cell motility and morphogenesis.
Ezrin Is an Essential Component of Brush
Border Microvilli
As a model, we used a cell line derived from kidney proxi-
mal tubules. During terminal differentiation these cells de-
velop a brush border composed of highly ordered mi-
crovilli; this cellular structure is specialized for absorption.
The microvilli core is organized by villin and fimbrin, two
actin bundling proteins, and is linked to the plasma mem-
brane by the brush border myosin I (Arpin and Friederich,
1992). Although the microvilli also contain ezrin, its role in
microvilli assembly is still poorly understood. Here we
show that ezrin is an essential component of microvilli for-
mation. A truncated variant of ezrin overproduced in
LLC-PK1 cells interferes with microvilli formation through a
dominant-negative mechanism. This is concomitant with
lack of localization of both the transfected NH2-terminal
Figure 6. Tubulogenesis by LLC-PK1 cell transfectants within collagen gels. Spherical cysts were formed by control LLC-PK1 cells (A)
and LLC-PK1 cells overproducing wild-type ezrin, grown under control conditions for 3 d. Small colonies were formed by LLC-PK1
cells overproducing the double phosphotyrosine-mutated ezrin-FF1 cells (B), and by cells overproducing the NH2-terminal domain of
ezrin under the same growth conditions. In the presence of 30 ng/ml of HGF, some cysts developed into tubules in LLC-PK1 cells (C);
the cysts developed in elongated tubules (three- to fivefold the control LLC-PK1 cells) in E7 cells (D). Inset represents a section of tu-
bules formed and demonstrates lumen formation. N2 cells (E) or the tyrosine mutants (F) did not form tubules. Bars: (A–F) 100 mm;
(inset) 25 mm.Crepaldi et al. Ezin Is an Effector of the HGF-mediated Signaling 431
domain and endogenous ezrin to the apical cell surface.
Notably, both molecules accumulate at the lateral sur-
faces, as do the few developed microvilli detected by EM.
It has been shown that ezrin suppression using an anti-
sense approach does not affect microvilli formation in a
thymoma cell line, unless performed in combination with
antisense oligonucleotides complementary to the sequence
coding for radixin and moesin (Takeuchi et al., 1994). To-
gether these results indicate that microvilli from different
tissue-derived cell lines can have diverse ERM protein
composition.
We cannot exclude the possibility that the dominant-
negative action of the NH2-terminal domain of ezrin also
affects radixin and moesin functions, since heterooligo-
merization between ezrin and moesin has been observed
(Gary and Bretscher, 1993). However, this hypothesis ap-
pears unlikely, since overproduction of radixin in LLC-
PK1 cells does not lead to the same phenotype as overpro-
duction of ezrin (unpublished observations).
How does the NH2-terminal domain of ezrin impede mi-
crovilli formation? There are several different hypotheses:
first, the NH2-terminal domain could prevent the interac-
tion of ezrin with membrane components essential for de-
velopment of the brush border, since it is this domain that
localizes to the plasma membrane (Algrain et al., 1993).
However, no microvillar membrane components which as-
sociate with ezrin have yet been identified. In BHK cells,
ERM proteins have been found associated with the inte-
gral membrane protein CD44 (Tsukita et al., 1994). The
NH2-terminal domain of moesin binds to CD44 with
higher affinity than full-length moesin (Hirao et al., 1996).
However, CD44 is present in several cell types, including
epithelial cells. In this latter case, CD44 is localized to the
basolateral surface of the polarized cells.
Although ezrin is mainly localized to microvilli in ma-
ture epithelial cells, it can be detected on the basolateral
surface of immature cells of intestinal crypts (Berryman et
al., 1993). Furthermore, in cells which do not have a well-
developed brush border, such as MDCK cells, a significant
proportion of ezrin is found associated with the lateral
membrane (unpublished results; Sato et al., 1992). We
propose that, depending on the cellular context, ezrin can
be recruited and can associate with membrane compo-
nents present on both the apical and the basolateral surface.
In addition, our results suggest that control of microvilli
assembly could occur at sites associated with the lateral
membranes, and this function could be suppressed by the
NH2-terminal domain through a dominant-negative effect.
Second, the NH2-terminal domain of ezrin could also
prevent microfilament organization. Although little is
known about such a role, an F-actin binding site has been
localized in the COOH-terminal domain of ezrin (Tu-
runen et al., 1994). Furthermore, there is substantial evi-
dence that the NH2-terminal domain of ezrin negatively
regulates the morphogenic activity of the COOH-terminal
domain (Martin et al., 1995) probably by an intra- or inter-
molecular association between these two domains (Berryman
et al., 1995; Gary and Bretscher, 1995). Thus overproduc-
tion of the truncated ezrin could impair ezrin oligomeriza-
tion. According to the model proposed by Berryman et al.
(1995), this oligomerization step could be essential for mi-
crovillus assembly.
Third, it is conceivable that ezrin exists as an inactive
molecule whose activation depends on signals regulating
the cryptic sites in the COOH- and NH2-terminal domains.
The ezrin NH2-terminal domain might interfere with the
activation of endogenous ezrin by competing with signal-
ing molecules that regulate the accessibility of cryptic
binding sites. For example, it has been shown that the as-
sociation of ERM proteins with CD44 is regulated by
phosphatidylinositol turnover and activation of Rho (Hirao
et al., 1996).
Ezrin Is a Downstream Target of HGF-R
The properties of ezrin and its ability to localize to differ-
ent compartments of epithelial cells prompted us to ana-
lyze whether ezrin could be a downstream effector of
HGF signaling. It has been shown that EGF stimulation of
cultured cells induces tyrosine phosphorylation of ezrin
and its concomitant oligomerization (Berryman et al.,
1995). The assembly of cell surface projections could re-
quire both ezrin oligomerization and stabilization of oligo-
mers by cytoskeleton interactions. Indeed, HGF stimula-
tion causes enrichment of ezrin in the detergent-insoluble,
cytoskeleton fraction. Here we show that ezrin is a sub-
strate of HGF-R both in vivo and in vitro.
We have already shown that the HGF receptor forms
complexes with Shc (Pelicci et al., 1995), PI3K (Graziani et
al., 1991), PLC-g, Grb-2-SOS, and pp60c-src (Ponzetto et
al., 1994). In LLC-PK1 cells ezrin is phosphorylated on ty-
rosine residues upon activation of the cells with HGF.
However, ezrin did not coprecipitate with the HGF-R in
LLC-PK1 cells while such an association was found in
MDCK cells. This might be due to the fact that, in LLC-
PK1 cells, a higher proportion of ezrin is associated with actin
cytoskeleton, in particular with microvilli microfilaments.
In LLC-PK1 cells the HGF-R associates in vivo with the
p62c-yes intracellular tyrosine kinase in a ligand-dependent
manner. We propose that p62c-yes, which is also found asso-
ciated with ezrin, could mediate ezrin interaction with
HGF-R in vivo. However, it is likely that other factors,
stimulated by HGF, including the above-mentioned lipid
kinases, mediate this interaction and possibly regulate
ezrin function. In vitro association experiments will tell us
whether the molecular association between ezrin and p62c-yes
that we have uncovered is direct or indirect. Whereas p60c-src
has a fundamental role in the cytoskeleton assembly of fo-
cal contacts (Thomas et al., 1995), a similar role on p62c-yes
is less clear, although a report of its enrichment in adher-
ens junctions is intriguing (Tsukita et al., 1991). However,
p62c-yes is also located near the apical plasma membrane of
epithelial cells in several tissues in vivo (Zhao et al., 1990)
and is enriched in detergent-resistant membrane com-
plexes containing glycosylphosphatidylinositol-anchored
apical membrane proteins in MDCK cells (Arreaza et al.,
1994). Altogether, these data suggest that ezrin and p62c-yes
together play a role in the cross talk between the lateral
and apical surfaces of epithelial cells.
Ezrin Triggers the Actin Cytoskeleton
Dynamics Required for HGF-mediated Cell Migration 
and Tubulogenesis
Receptor tyrosine kinases play important roles in the dif-The Journal of Cell Biology, Volume 138, 1997 432
ferentiation of epithelial cells. It has been recently shown
that among tyrosine kinase receptors present on epithelial
cells only the HGF-receptor is able to induce branching
morphogenesis of kidney epithelial cells in collagen ma-
trix, whereas the other receptors induce only scattering of
cells (Sachs et al., 1996). It has been proposed that growth
factor–induced cell motility and morphogenesis imply spe-
cific signals. Here we have shown that overproduction of
the ezrin protein and suppression of its function by two
different dominant-negative mutants critically affect the
HGF-mediated signaling. One of the important conclu-
sions that can be drawn from this study, although limited
to this specific cell line, is that ezrin is an effector of the
HGF-induced cell migration and morphogenesis.
Rearrangements of actin cytoskeleton underlie the HGF-
induced cell motility, as suggested by cytochalasin B pre-
vention of MDCK cell scattering (Rosen et al., 1990). The
small GTP-binding proteins, Ras and Rac, have been
shown to act downstream of the HGF-receptor and to me-
diate cell spreading but not motility (Ridley et al., 1995).
Thus, scattering requires additional signals which are
likely to include regulation of specific actin-binding pro-
teins. Overproduction of ezrin increased cell motility in re-
sponse to HGF treatment as measured by the ability of
LLC-PK1 cells to close a wound. Similar results were ob-
tained with overproduction of gelsolin in fibroblast cells
(Cunningham et al., 1991). Conversely, the HGF-medi-
ated cell migration was blocked by the introduction of the
NH2-terminal domain of ezrin and by the ezrin mutated on
two tyrosine residues. We propose that changes in ezrin
phosphorylation and/or conformation induced by HGF
stimulation modify the state of actin organization in the
cell cortex.
Our observation that overproduction of ezrin induces
formation of very long tubules when LLC-PK1 cells are
cultured in collagen gels in the presence of HGF and that
ezrin mutants inhibit tubule formation confirms our view
that ezrin plays an important role in HGF-induced mor-
phogenesis. At present, the mechanisms are unclear. How-
ever, the results obtained in motility assays suggest that cy-
toskeletal rearrangements may affect tubule formation. Of
course, ezrin could be involved in other significant aspects
of tubulogenesis. Tubulogenesis requires extensive remod-
eling of the extracellular matrix and modulation of adhe-
sion. HGF participates in this remodeling by increasing
the synthesis of matrix-degrading enzymes (Pepper et al.,
1992), and by down-regulating the expression of specific
collagen adhesion integrins (Berdichevsky et al., 1994).
Ezrin might transmit and integrate signals elicited by
HGF-R and cell adhesion molecules, since it has been
shown to interact with CD44, the hyaluronan adhesion re-
ceptor (Tsukita et al., 1994).
It is known that control of cell shape influences gene ex-
pression and cell differentiation (Boudreau et al., 1995).
Increased ezrin content might also potentiate signaling
pathways important for morphogenesis. It has been shown
that in NIH3T3 cells transformed with v-Fos, overproduc-
tion of c-Fos leads to an increase of ezrin level and to mor-
phological changes (Jooss and Muller, 1995).
Lastly, ezrin might have a role in regulating cell growth.
This role has been shown for a member of the band 4.1
family, merlin/schwannomin, whose gene has been charac-
terized as the tumor suppressor gene responsible for neu-
rofibromatosis type 2 (Rouleau et al., 1993; Trofatter et
al., 1993). Moreover, the level of ezrin has been found to
be increased in immortalized mouse fibroblasts (Kaul et
al., 1996).
We propose that ezrin is able to convey the signals elic-
ited by growth factor receptors to the actin cytoskeleton
machinery. Different signals can be integrated by ezrin to
engage actin cytoskeleton in different, but possibly related
functions such as apical domain morphogenesis and cell
locomotion. Our findings may unveil new roles for ezrin in
epithelial differentiation and carcinogenesis.
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